indomethacin has been researched along with Alopecia in 7 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Alopecia: Absence of hair from areas where it is normally present.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral administration for 6 days of 100 mg/kg MMK-1, an agonist peptide selective for the FPRL1 receptor, suppressed alopecia induced by the anticancer drug etoposide in neonatal rats." | 7.73 | Orally administered FPRL1 receptor agonist peptide MMK-1 inhibits etoposide-induced alopecia by a mechanism different from intraperitoneally administered MMK-1. ( Tsuruki, T; Yoshikawa, M, 2006) |
| "Previously, we found that orally administered soymetide-4 (MITL), an immunostimulating peptide derived from soybean beta-conglycinin alpha' subunit, suppressed alopecia induced by the anti-cancer drug etoposide in neonatal rats." | 3.73 | Anti-alopecia mechanisms of soymetide-4, an immunostimulating peptide derived from soy beta-conglycinin. ( Takahata, K; Tsuruki, T; Yoshikawa, M, 2005) |
| "Oral administration for 6 days of 100 mg/kg MMK-1, an agonist peptide selective for the FPRL1 receptor, suppressed alopecia induced by the anticancer drug etoposide in neonatal rats." | 3.73 | Orally administered FPRL1 receptor agonist peptide MMK-1 inhibits etoposide-induced alopecia by a mechanism different from intraperitoneally administered MMK-1. ( Tsuruki, T; Yoshikawa, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Sasaki, R | 1 |
| Asano, Y | 1 |
| Fujimura, T | 1 |
| RodrÃguez-Lobato, E | 1 |
| Morgado-Carrasco, D | 1 |
| Giavedoni, P | 1 |
| Ferrando, J | 1 |
| Tsuruki, T | 2 |
| Takahata, K | 1 |
| Yoshikawa, M | 2 |
| Sredni, B | 1 |
| Xu, RH | 1 |
| Albeck, M | 1 |
| Gafter, U | 1 |
| Gal, R | 1 |
| Shani, A | 1 |
| Tichler, T | 1 |
| Shapira, J | 1 |
| Bruderman, I | 1 |
| Catane, R | 1 |
| Kaufman, B | 1 |
| Whisnant, JK | 1 |
| Mettinger, KL | 1 |
| Kalechman, Y | 1 |
| Kodama, H | 1 |
| Umemura, S | 1 |
| Nohara, N | 1 |
| Lazar, M | 1 |
| Weiner, MJ | 1 |
| Leopold, IH | 1 |
1 trial available for indomethacin and Alopecia
| Article | Year |
|---|---|
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models.
Topics: Alopecia; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; C | 1996 |
6 other studies available for indomethacin and Alopecia
| Article | Year |
|---|---|
A pediatric case of corticosteroid-resistant erosive pustular dermatosis of scalp-like alopecia treated successfully with oral indomethacin, doxycycline, and topical tacrolimus.
Topics: Adrenal Cortex Hormones; Alopecia; Child; Doxycycline; Humans; Indomethacin; Male; Scalp; Scalp Derm | 2022 |
Alopecic and aseptic nodule of the scalp in a girl.
Topics: Administration, Topical; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Child; Female; Humans; I | 2017 |
Anti-alopecia mechanisms of soymetide-4, an immunostimulating peptide derived from soy beta-conglycinin.
Topics: Adjuvants, Immunologic; Administration, Oral; Alopecia; Animals; Antigens, Plant; Antineoplastic Age | 2005 |
Orally administered FPRL1 receptor agonist peptide MMK-1 inhibits etoposide-induced alopecia by a mechanism different from intraperitoneally administered MMK-1.
Topics: Administration, Oral; Alopecia; Animals; Cimetidine; Disease Models, Animal; Etoposide; Female; Indo | 2006 |
Follicular mucinosis: response to indomethacin.
Topics: Administration, Oral; Administration, Topical; Alopecia; Humans; Indomethacin; Male; Middle Aged; Mu | 1988 |
Treatment of uveitis with methotrexate.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Alopecia; Anti-Bacterial Agents; Child; | 1969 |